In Focus: Small Business–Big Opportunities

| 01 October 2008

There are two ways of looking at today's biomedical industry. There is the doomsday scenario based upon dwindling revenues, increasing competition from generics and pipelines drying up, leading to corresponding stock plunges and job cuts. Then there is the rosy picture of small businesses rising up to replenish faith in the industry through focused product development that leads to better therapies and increasing profits. In this month's Regulatory Focus, we decided to go with the latter.


© 2023 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy